Evidence map›Paper›PMID 42368280›Full record

ArticleFrontiers in pediatrics2026

Efficacy and safety of sini powder combined with Xiaoxianxiong decoction for adolescent depression with liver qi stagnation and phlegm-heat obstruction syndrome: a randomized controlled trial.

Ruiyu Lin, Yangzhen Liu, Juncheng Li, Jia Gao, Liting He, Shanying Huang

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruiyu LinThe Third Hospital of Mianyang, Mianyang, Sichuan, China.
Yangzhen LiuDepartment of Pediatrics, Youxian District Hospital of Traditional Chinese Medicine (Youxian Branch of The Third Hospital of Mianyang), Mianyang, Sichuan, China.
Juncheng LiDepartment of Pediatrics, Youxian District Hospital of Traditional Chinese Medicine (Youxian Branch of The Third Hospital of Mianyang), Mianyang, Sichuan, China.
Jia GaoDepartment of Pediatrics, Youxian District Hospital of Traditional Chinese Medicine (Youxian Branch of The Third Hospital of Mianyang), Mianyang, Sichuan, China.
Liting HeDepartment of Pediatrics, Youxian District Hospital of Traditional Chinese Medicine (Youxian Branch of The Third Hospital of Mianyang), Mianyang, Sichuan, China.
Shanying HuangThe Third Hospital of Mianyang, Mianyang, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess efficacy and safety of Sini San combined with Xiaoxianxiong Tang as add-on therapy for adolescents (12-18 years) with liver qi stagnation and phlegm-heat depression, and to provide preliminary evidence for TCM syndrome-based treatment. Methods: Sixty adolescents (12-18 years) with moderate depression (DSM-5 criteria) meeting TCM syndrome standards were recruited from Youxian Branch of Mianyang Third Hospital (Jan 2024-Dec 2025). Sample size was calculated via G*Power 3.1 (effect size=0.8, Results: Baseline characteristics were comparable between groups (all Conclusion: As an add-on therapy to psychological counseling, Sini San combined with Xiaoxianxiong Decoction shows preliminary short-term efficacy in alleviating depressive symptoms and improving quality of life in adolescents with target TCM syndrome, with favorable short-term safety. Due to small sample size, single-center design, lack of double-blinding and placebo control, the findings are hypothesis-generating and cannot support broad clinical promotion.

Indexed as

add-on therapyadolescent depressionChinese medicinal compoundclinical efficacyliver qi stagnationphlegm-heat blocking the middle energizerrandomized controlled trialsafety

Identifiers

PMID42368280
PMCPMC13303901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.